Journal
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 23, Issue 3, Pages 246-264Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557522666220512151454
Keywords
Protein data bank (PDB); structure-based drug design (SBDD); TNF-alpha converting enzyme (TACE); Swine Flu; 11 Beta hydroxysteroid dehydrogenase type 1 (11 beta-HSD1); DprE1; SARS-CoV-2 M-pro
Categories
Ask authors/readers for more resources
The selection of the right protein structure is crucial for the success of drug discovery through structure-based design. This study presents a systematic approach for choosing the appropriate type of protein structure, with case studies on TACE, 11 beta-HSD1, DprE1, and SARS-CoV-2 M-pro enzymes for illustration.
The selection of a protein structure is an important step for the success of the drug discovery process using structure-based design. Selection of the right crystal structure is critical as multiple crystal structures are available for the same protein in the Protein Data Bank (PDB). In this communication, we have discussed a systematic approach for selecting the right type of protein structure. Selecting crystal structures of TACE, 11 beta-HSD1, DprE1, and SARS-CoV-2 M-pro enzymes for some case studies have been discussed for illustration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available